Don't miss

Replay


LATEST SHOWS

THE DEBATE

Hard Brexit, here we come: UK to leave EU common market (part 1)

Read more

THE DEBATE

Hard Brexit, here we come: The blowback against globalisationt (part 2)

Read more

ENCORE!

Art on the wire and online: Jean-Hubert Martin on curating in cyberspace

Read more

FOCUS

Inside China's answer to Silicon Valley

Read more

ACCESS ASIA

Behind the scenes at China's Harbin snow festival

Read more

THE INTERVIEW

'Donald Trump is a great friend of Israel'

Read more

BUSINESS DAILY

Davos 2017: World Economic Forum wary of post-Brexit future

Read more

IN THE PAPERS

'Great Brexpectations'

Read more

IN THE PAPERS

Trump's anti-European 'attack'

Read more

China seeks volunteers for AIDS vaccine trials

Latest update : 2009-03-21

China, where between 30 and 50 million people may be at risk from the disease, is seeking volunteers to undergo a second phase of human trials on an AIDS vaccine.

AFP - Chinese scientists are seeking volunteers to undergo a second phase of human trials on an AIDS vaccine, state media reported Saturday.

China began research into an AIDS vaccine 13 years ago and conducted its first phase of clinical trials on 49 people aged between 18 and 50 in the Guangxi region of southern China in 2005, the Xinhua news agency said.

"The recipients of the vaccine do not show any signs of adverse effects. Immune tests for the vaccine have also proved favourable results," said Kong Wei, one of the programme's team leaders.

Researchers said they wanted to enroll another 30 volunteers for the second phase of tests for the vaccine, which must undergo three lots of clinical trials before it can be approved for use.

Officially, China had 276,630 AIDS cases in 2008 and 38,100 deaths, but experts say the true figure is much higher as the tally refers only to confirmed incidents of the condition.

UNAIDS estimates that between 30 and 50 million people may be at risk from the disease in China, where transmission through sexual activity is increasingly common.
 

Date created : 2009-03-21

COMMENT(S)